Local Institution

Orbassano(To) 10043

0 studies enrolling now · 4 studies all time

What they study most

Leukemia, Leukemia, Lymphoblastic, Acute, Philadelphia-Positive, Myeloid Leukemia, Chronic, Myeloid Leukemia, Chronic, Accelerated Phase

Studies at this site

• A Phase III Study of Dasatinib vs Imatinib in Patients With Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia — Completed
• Dasatinib Combination Therapy With the Smoothened (SMO) Inhibitor BMS-833923 in Chronic Myeloid Leukemia (CML) — Completed
• Long-term Safety of Dasatinib in Patients With Chronic Myelogenous Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia — Completed
• Advanced Chronic Myelogenous Leukemia (CML) - Follow On: Study of BMS-354825 in Subjects With CML — Completed